This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Evelhoch, J. L. Articles by Corbett, T. H. Search for Related Content PubMed PubMed Citation Articles by Evelhoch, J. L. Articles by Corbett, T. H.

Flavone Acetic Acid (NSC 347512)-induced Modulation of Murine Tumor Physiology Monitored by in Vivo Nuclear Magnetic Resonance Spectroscopy¹

Division of Hematology and Oncology, Department of Internal Medicine, Wayne State University School of Medicine, Detroit, Michigan 48201-1998

Flavone acetic acid (FAA), a new drug with broad activity against transplanted solid tumors of mice, induces nonrepairable DNA single strand breaks that correlate with therapeutic efficacy. To test the hypothesis that the inability of the cells to repair single strand breaks is associated with a disruption of tumor energy metabolism, in vivo ³¹P nuclear magnetic resonance (NMR) spectra were acquired from s.c. implanted Glasgow osteogenic sarcomas in C57BL/6 x DBA/2 F₁ mice both before and after treatment with FAA i.v. at 100, 150, or 200 mg/kg and from a control (no treatment) group (n = 4 in each group), While FAA produced a dose-dependent decrease in both the nucleoside triphosphates level and pH, only treatment with an efficacious dose of 200 mg/kg resulted in both a reduction in pH and a complete loss of nucleoside triphosphates from the NMR spectrum at 4 h with no recovery until 48 h and little recovery out to 72 h. The ATP concentration determined by high pressure liquid chromatography in a parallel set of experiments was 5.59 ± 1.16 (SE) µmol/g (wet weight) in control tumors (n = 9) and 0.24 ± 0.12 µmol/g (wet weight) at 4 h after 200 mg/kg FAA (n = 7). To examine the possibility that the loss of ATP and decreased pH are associated with a reduction in tumor blood flow, we used ²H NMR to monitor the washout of D₂O injected directly into the tumor both before and 4 h after treatment with 200 mg/kg FAA. The pretreatment tumor blood flow of 12.4 ± 1.7 ml/min/100 g was reduced to 1.9 ± 0.5 ml/min/100 g at 4 h after treatment (n = 3). The FAA-induced reduction of both tumor blood flow and ATP may play an important role in its mechanism of action and should be considered in the combination of FAA with other drugs or therapeutic modalities. In addition, because ³¹P NMR can be used clinically, it should provide a nonambiguous early indicator of activity for clinical trials of FAA.

¹ Support for this work was provided by the Wayne State University Ben Kasle Trust for Cancer Research and NIH Grants R01-CA42449 and P30-CA22453.

² To whom requests for reprints should be addressed.

Received 2/11/88. Revised 5/18/88. Accepted 5/27/88.

This article has been cited by other articles:

				M. H. Pham, N. Auzeil, A. Regazzetti, D. Dauzonne, A. Dugay, M.-C. Menet, D. Scherman, and G. G. Chabot Identification of New Flavone-8-Acetic Acid Metabolites Using Mouse Microsomes and Comparison with Human Microsomes Drug Metab. Dispos., November 1, 2007; 35(11): 2023 - 2034. [Abstract] [Full Text] [PDF]